市场概况

The global medical aesthetics market is experiencing rapid growth, 年复合增长率 (复合年增长率) 的 13.71% projected from 2022 到 2027. It is anticipated to reach USD 45.52 十亿 2027, 从美元上涨 21 十亿 2021. Several trends are driving this market expansion. Firstly, there is an increasing number of consumers seeking aesthetic procedures at a younger age. 此外, there has been a rise in men seeking cosmetic enhancement procedures. 而且, there is a growing preference for non-invasive cosmetic procedures over surgical options.

The market is witnessing the introduction of advanced and innovative devices and products from both global and local vendors. Facelifts, liposuction, botox and neuromodulators, 皮肤重修, and intense pulse light procedures are experiencing high demand across various age groups.

Despite the barriers and restrictions imposed by the COVID-19 pandemic, there has been a healthy 3% rise in the demand for cosmetic treatments compared to 2019. This indicates a strong preference for improving one’s appearance and presents significant opportunities for the medical aesthetics market in the future.

Platelet-rich plasma (PRP) is a highly popular cosmetic injectable treatment within the global medical aesthetics market. It utilizes the patient’s own platelet-rich blood cells to naturally rejuvenate the skin and treat signs of aging. PRP has gained popularity in recent years due to its safety and ability to deliver rapid results. This procedure is commonly used for hair loss and skin rejuvenation, particularly in treating male pattern baldness. Dermatologists and plastic surgeons in high-income countries highly recommend PRP for improving skin appearance and overall health.

Advancements in medical aesthetics procedures are expected to contribute to significant market growth. The field of aesthetic dermatology, including innovations in botanical blends for hair care and skincare, has witnessed notable changes in recent years. These advancements have reduced side effects and paved the way for numerous procedures. Laser applications are widely adopted for treating vascular birthmarks, hemangioma, and other skin issues.

The demand for minimally invasive and non-invasive aesthetic procedures has seen a surge in recent years, appealing to all demographics. Non-invasive treatments, 尤其, have become an accessible entry point for individuals, including men and young people who are highly conscious of their appearance. These procedures are favored by consumers due to their affordability, minimal downtime, and lower risk compared to invasive options.

The increasing per capita expenditure on personal care and cosmeceuticals, coupled with growing awareness of medical aesthetic solutions, has significantly driven market growth. 在 2022, the Aesthetic Society reported a high market growth resulting from increased spending on aesthetic procedures. Approximately USD 9.3 billion was spent on aesthetic procedures in 2020, with around USD 3 billion allocated to non-invasive treatments and USD 6 billion to invasive procedures. This represents an 80% growth in expenditure compared to 2019 when approximately USD 8.2 billion was spent on aesthetic procedures.

Both the youth and aging populations are major users of medical aesthetics treatments. These treatments have evolved from anti-aging creams to approved cosmetic procedures. 现在, an increasing number of young individuals are turning to such procedures to prevent the signs of aging.

Medical tourism is also contributing to the surge in medical aesthetic procedures. Patients are traveling abroad for cosmetic surgery, driven by factors such as the globalization of medical services, the desire to display a healthy lifestyle, an emphasis on physical appearance, and the willingness to travel. This has given rise to a new segment in health tourism known as aesthetic medicine tourism.

市场细分

市场根据多种因素进行细分, including procedures, 产品, 应用, 最终用户, 和地理.

Segmentation by Procedures
Minimally Invasive
Non-Invasive

按产品细分
Body Contouring Devices
Laser & Energy Based Devices
Cosmetic Implants
Derma Filler & Neuromodulators
Microneedling & Chemical Peels
Microdermabrasion
其他

按应用细分
Body Contouring & Cellulite Reduction
紧肤 & Skin Lighteners
Facial Aesthetic
Breast Augmentation
其他的

按最终用户细分
Hospital & 皮肤诊所
医疗水疗 & Beauty Centres
Homecare

按地理位置细分
北美 – 我们, 加拿大
欧洲 – 德国, 法国, 英国, 意大利, 西班牙
亚太地区 – 中国, 日本, 印度, 韩国, 澳大利亚
拉美 – 巴西, 墨西哥, 阿根廷
中东 & 非洲 – 南非, 沙特阿拉伯, 火鸡

The medical aesthetics market encompasses various procedures aimed at enhancing the physical appearance and satisfaction of patients. These procedures can be categorized as non-invasive or minimally invasive. 在 2021, minimally invasive procedures accounted for the highest market share at 57.14%, while non-invasive procedures held a 42.86% 市场份额. The popularity of minimally invasive and non-invasive aesthetic procedures is on the rise globally due to their advantages such as minimal surgical intervention, shorter recovery time, reduced pain, and higher safety and efficacy.

When considering product types in the global medical aesthetics market, body contouring devices dominate with a 27.38% 市场份额. Other product segments include laser and energy-based devices, cosmetic implants, dermal fillers and neuromodulators, micro-needling and chemical peels, microdermabrasion, and others such as thread lifts and skin lighteners. The increasing number of minimally invasive procedures for fat reduction and body shaping drives the growth of the body contouring devices segment. Laser and energy-based devices follow closely behind with a 21.86% 市场份额, indicating rapid industry growth.

In terms of applications, the key segments in the global medical aesthetics market are body contouring and cellulite reduction, skin tightening and resurfacing, facial aesthetics, breast augmentation, 和别的. 在这些当中, the body contouring and cellulite reduction segment holds the largest market share at 30.58%. The growing demand for fat reduction, cellulite reduction, and liposuction procedures contributes to the growth of this segment. 此外, skin tightening and resurfacing procedures have gained popularity in recent years and are expected to experience significant growth in the near future.

In the context of end-users, the global medical aesthetics market is categorized into hospitals and skin clinics, 医疗水疗中心和美容中心, and homecare. 在 2021, hospitals and skin clinics dominated with a 55.24% 市场份额. The increasing demand for minimally invasive and non-invasive procedures, coupled with growing awareness, drives more patients to visit hospitals and skin clinics for medical aesthetic treatments. These settings provide easily accessible and advanced treatment options, further fueling the growth of this segment.

North America currently holds the largest share in the global medical aesthetics market and is projected to grow at a CAGR of 12.52% 在预测期内. Factors driving market growth in this region include higher expenditure on medical aesthetic procedures, well-established healthcare infrastructure, and easy access to such procedures. 北美境内, the United States is a key contributor to significant industry growth, with high demand for liposuction, breast augmentation, and tummy tuck procedures.

Among all regions, 亚太地区 (亚太地区) is expected to witness faster growth, with a CAGR of approximately 15% 在预测期内. This is attributed to factors such as a rising aging population, increased acceptance and demand for cosmetic surgeries, and higher expenditure on medical aesthetic procedures. Countries like Japan, 中国, 印度, 韩国, and Australia are experiencing significant improvements in access to medical aesthetic procedures, indicating promising market growth opportunities.

竞争格局

The global medical aesthetics market is characterized by intense competition and a dynamic environment, with numerous vendors at the international, 区域性的, and local levels offering a wide range of medical aesthetic products, 治疗, and devices to consumers. Prominent industry players such as AbbVie (Allergan), Sisram Medical, Cutera Inc., Lumenis Inc., 鲍什 & Lomb, and El En Spa consistently exert significant influence on the competitive landscape.

地理上, many industry players are headquartered in the United States, 日本, 欧洲, and the Asia-Pacific (亚太地区) 地区. AbbVie, a key player based in the United States, holds a leading position in the medical aesthetics market, providing innovative and advanced solutions for addressing critical health issues. 在 2021, AbbVie’s acquisition of Allergan, a major player in the medical aesthetics market, expanded their product portfolio. 此外, AbbVie’s product category includes the highly sought-after and popular Botox, which further contributes to the industry’s fierce competition.

Key companies profiled in this report include AbbVie (Allergan), Bausch Health Companies, Candela, Cutera, Cynosure, EL.En. S.p.A., 高德玛, 约翰逊 & 约翰逊, Lumenis, Merz Pharma, Sientra, Sinclair, Sisram Medical, Aerolase, Aesthetics Biomedical, Asclepion Laser Technologies, Astanza Laser, Beijing Sanhe Beauty S & T Co., Beijing ADSS Development, Biolitec, Biotec Italia, BISON Medical, Bluecore Company, Brera Medical Technologies S.R.L., BTL Aesthetics, Cartessa Aesthetics, Dominion Aesthetic Technologies, Erchonia, ENDYMED, F Care Systems, Gigaalaser, GSD – Global Skin Dermatologist, InMode Aesthetic Solutions, Leaflife Technology, LINLINE Medical Systems, Lutronic, Lynton Lasers, MedArt ApS, Microaire Surgical Instruments, Medytox, Meyer-Haake, PhotoMedex, Revance Aesthetics, Sciton, ThermiGen, Venus Concept, Wavemed, Zimmer MedizinSysteme.

已回答的关键问题

What is the size of the global medical aesthetics market?

The global medical aesthetics market had a valuation of USD 21.05 十亿 2021 预计将达到美元 45.52 十亿 2027.

What is the growth rate of the global medical aesthetics market?

The global medical aesthetics market is anticipated to grow at a compound annual growth rate (复合年增长率) 的 13.71% 从 2022 到 2027.

What are the current trends in the global medical aesthetics market?

Some notable trends in the global medical aesthetics market include rapid advancements in the application of platelet-rich plasma (PRP) in medical aesthetics, continuous progress in the field of medical aesthetics, and the emergence of new medical aesthetic treatments and developments.

Who are the key players in the global medical aesthetics market?

Leading companies in the global medical aesthetics market include AbbVie (Allergan), Bausch Health Companies, Candela, Cutera, Cynosure, EL.En. S.p.A., 高德玛, 约翰逊 & 约翰逊, Lumenis, Merz Pharma, Sientra, Sinclair, and Sisram Medical.

Which region is expected to dominate the global medical aesthetics market share?

North America is projected to dominate the global medical aesthetics market, 占 45% of the revenue share. The region’s dominance is attributed to its high expenditure capacity for aesthetic procedures and a significant level of awareness among the population, which drives market growth in this region.